PAA 2.50% 20.5¢ pharmaust limited

PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III, page-500

  1. 284 Posts.
    lightbulb Created with Sketch. 377
    A most interesting article. Some pet owners report no adverse effects even after 6 months despite expected adverse events with combination of prednesilone.

    This is our first clue that monepantel IS actually working in the dogs on compassionate usage after completion of the formal 28 day trial.

    I'm sure Vet Major will be following this with great interest.


 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.